data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Tricida
(NASDAQ:TCDA)
$0.2481
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$0.2375
-0.0106[-4.27%]
After Hours: 7:57PM EDT
Day Range- - -52 Wk Range0.19 - 13.85Open / Close- / -Float / Outstanding33.6M / 58M
Vol / Avg.- / 10.1MMkt Cap14.4MP/E-50d Avg. Price4.99
Div / Yield-Payout Ratio-Total Float33.6MEPS-0.44

Tricida Stock (NASDAQ:TCDA), Quotes and News Summary

Tricida Stock (NASDAQ: TCDA) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range0.19 - 13.85Open / Close- / -Float / Outstanding33.6M / 58M
Vol / Avg.- / 10.1MMkt Cap14.4MP/E-50d Avg. Price4.99
Div / Yield-Payout Ratio-Total Float33.6MEPS-0.44
Business Wire - Nov 14, 2022, 4:05PM
Business Wire - Nov 2, 2022, 4:05PM
Business Wire - Oct 24, 2022, 7:00AM
Business Wire - Oct 19, 2022, 4:05PM
Business Wire - Oct 13, 2022, 11:00AM
Business Wire - Oct 3, 2022, 8:30AM
Business Wire - Sep 23, 2022, 10:50PM
Globe Newswire - Sep 15, 2022, 3:02PM
PRNewswire - Sep 9, 2022, 10:50PM
Business Wire - Sep 6, 2022, 10:00AM
Business Wire - Aug 26, 2022, 10:50PM
Business Wire - Aug 8, 2022, 4:05PM
Newsfile - Aug 2, 2022, 7:05PM
Globe Newswire - Aug 1, 2022, 10:00AM
Globe Newswire - May 19, 2022, 8:30AM
Globe Newswire - May 10, 2022, 4:05PM
Globe Newswire - May 3, 2022, 10:00AM
Globe Newswire - Apr 1, 2022, 10:00AM
Globe Newswire - Mar 29, 2022, 4:05PM
Globe Newswire - Mar 16, 2022, 10:00AM
Globe Newswire - Mar 2, 2022, 4:26PM
Globe Newswire - Mar 1, 2022, 1:30PM
Business Wire - Feb 9, 2022, 4:38PM
Globe Newswire - Jan 4, 2022, 10:00AM
Globe Newswire - Dec 15, 2021, 1:58PM
InvestorsObserver - 2 days ago
InvestorsObserver - 3 days ago
TipRanks - Nov 15, 2022, 5:25AM
InvestorsObserver - Nov 3, 2022, 12:44PM
Seeking Alpha - Nov 2, 2022, 4:30PM
InvestorsObserver - Nov 1, 2022, 1:11PM
InvestorsObserver - Oct 27, 2022, 11:31AM
InvestorsObserver - Oct 26, 2022, 1:42PM
InvestorsObserver - Oct 25, 2022, 12:27PM
InvestorsObserver - Oct 24, 2022, 2:42PM
InvestorPlace - Oct 24, 2022, 12:03PM
InvestorPlace - Oct 24, 2022, 11:18AM
Seeking Alpha - Oct 24, 2022, 7:57AM
InvestorsObserver - Oct 21, 2022, 11:14AM
Seeking Alpha - Oct 19, 2022, 5:00PM
Seeking Alpha - Oct 19, 2022, 5:00PM
InvestorsObserver - Oct 12, 2022, 3:53PM
TipRanks - Oct 12, 2022, 7:44AM
InvestorsObserver - Oct 11, 2022, 12:30PM
InvestorsObserver - Oct 7, 2022, 11:52AM
TipRanks - Oct 3, 2022, 6:35AM
TipRanks - Oct 2, 2022, 5:04AM
TipRanks - Oct 2, 2022, 5:04AM
InvestorsObserver - Sep 26, 2022, 11:50AM
InvestorsObserver - Sep 22, 2022, 2:44PM
Seeking Alpha - Sep 21, 2022, 8:00AM
InvestorsObserver - Sep 20, 2022, 2:16PM
InvestorsObserver - Sep 13, 2022, 2:40PM
TipRanks - Sep 10, 2022, 1:00PM
TipRanks - Sep 9, 2022, 8:00AM
TipRanks - Sep 8, 2022, 8:13AM
InvestorsObserver - Aug 30, 2022, 3:37PM
InvestorsObserver - Aug 9, 2022, 11:35AM
TipRanks - Aug 9, 2022, 7:11AM
Seeking Alpha - Aug 8, 2022, 9:00PM
Sector: Health Care.Industry: Pharmaceuticals
Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.540-0.430 0.1100
REV0
Q2 2022Est.ActualSurprise
EPS-0.580-0.370 0.2100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Tricida (TCDA) stock?

A

You can purchase shares of Tricida (NASDAQ: TCDA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Tricida's (TCDA) competitors?

Q

What is the target price for Tricida (TCDA) stock?

A

The latest price target for Tricida (NASDAQ: TCDA) was reported by JP Morgan on Tuesday, October 25, 2022. The analyst firm set a price target for 0.00 expecting TCDA to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Tricida (TCDA)?

A

The stock price for Tricida (NASDAQ: TCDA) is $0.2481 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Tricida (TCDA) pay a dividend?

A

There are no upcoming dividends for Tricida.

Q

When is Tricida (NASDAQ:TCDA) reporting earnings?

A

Tricida’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q

Is Tricida (TCDA) going to split?

A

There is no upcoming split for Tricida.

Q

What sector and industry does Tricida (TCDA) operate in?

A

Tricida is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.